SAS-B approvals hit 10,755 in July, up from June’s adjusted figure of 10,415 and a record monthly total.
The number of Authorised Prescribers was also up from 263 to 341.
The Therapeutic Goods Administration has now approved more than 140,000 SAS-B applications for unapproved medicinal cannabis products.
